|
Achieving Blood Pressure targets
|
|
|
Cardio-renal continuum
|
|
|
USE OF RAAS SUPPRESSION
|
|
|
Meta-Analysis based on US New Drug Application
|
|
|
Schematic of Study Design
|
|
|
24-Hour Mean Systolic BP by ABPM
|
|
|
24-Hour Mean Diastolic BP by ABPM
|
|
|
24-Hour Systolic BP Profile by ABPM
|
|
|
Safety & Tolerability
|
|
|
Study Design
|
|
|
Primary Efficacy Endpoint
|
|
|
Change by Study Week
|
|
|
Change in SBP by ABPM
|
|
|
Safety Results
|
|
|
Study DesignAzilsartan Medoxomil
|
|
|
|
ABPM and Azilsartan Medoxomil
|
|
|
PHARMACOLOGICAL NEEDINGS IN HYPERTENSION
|
|
Share this page with your colleagues and friends: